What is it that biopharma companies, research institutions, and healthcare facilities all have in common? Their interest in genomic data. This also means big business when it comes to processing, protecting, and managing data.
DNAnexus enjoyed a $58 million round of financing led by new investor Foresite Capital, with strategic investment from Microsoft. Existing investors, GV (Formerly Google Ventures, TPG Biotech, WuXi NextCODE, Claremont Creek Ventures, and MidCap Financial also participated to ensure the continued development of the exciting startup.